Literature DB >> 33408768

The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis.

Javier Muñoz-Garcia1,2, Denis Cochonneau1, Stéphane Télétchéa3, Emilie Moranton1, Didier Lanoe1, Régis Brion4, Frédéric Lézot4, Marie-Françoise Heymann1, Dominique Heymann1,5.   

Abstract

Macrophages are specialized cells that control tissue homeostasis. They include non-resident and tissue-resident macrophage populations which are characterized by the expression of particular cell surface markers and the secretion of molecules with a wide range of biological functions. The differentiation and polarization of macrophages relies on specific growth factors and their receptors. Macrophage-colony stimulating factor (CSF-1) and interleukine-34 (IL-34), also known as "twin" cytokines, are part of this regluatory landscape. CSF-1 and IL-34 share a common receptor, the macrophage-colony stimulating factor receptor (CSF-1R), which is activated in a similar way by both factors and turns on identical signaling pathways. However, there is some discrete differential activation leading to specific activities. In this review, we disscuss recent progress in understanding of the role of the twin cytokines in macrophage differentiation, from their interaction with CSF-1R and the activation of signaling pathways, to their implication in macrophage polarization of non-resident and tissue-resident macrophages. A special focus on IL-34, its involvement in pathophsyiological contexts, and its potential as a theranostic target for macrophage therapy will be proposed. © The author(s).

Entities:  

Keywords:  IL-34; inflammation; macrophage differentiation; theranostics; tumor

Year:  2021        PMID: 33408768      PMCID: PMC7778581          DOI: 10.7150/thno.50683

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


  235 in total

1.  [Disruption of interactions between immunocytes, glia and neurons in demyelinating diseases: a view from neuroscience].

Authors:  Tetsuya Mizuno
Journal:  Rinsho Shinkeigaku       Date:  2011-11

2.  Interleukin-34 induces monocytic-like differentiation in leukemia cell lines.

Authors:  Burthia E Booker; Ryan S Clark; Samuel T Pellom; Samuel E Adunyah
Journal:  Int J Biochem Mol Biol       Date:  2015-03-20

Review 3.  The role of Kupffer cells in hepatic diseases.

Authors:  Peizhi Li; Kun He; Jinzheng Li; Zuojin Liu; Jianping Gong
Journal:  Mol Immunol       Date:  2017-03-15       Impact factor: 4.407

Review 4.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.

Authors:  Seyed Mohammadali Dadfar; Karolin Roemhild; Natascha I Drude; Saskia von Stillfried; Ruth Knüchel; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2019-01-11       Impact factor: 15.470

Review 5.  Novel Target Selection for Nuclear Medicine Studies.

Authors:  Sze Ting Lee; I Burvenich; A M Scott
Journal:  Semin Nucl Med       Date:  2019-07-06       Impact factor: 4.446

Review 6.  Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).

Authors:  Wei Liu; Xianlong Zhang
Journal:  Mol Med Rep       Date:  2015-01-07       Impact factor: 2.952

7.  Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.

Authors:  Laurence Duplomb; Marc Baud'huin; Céline Charrier; Martine Berreur; Valérie Trichet; Frédéric Blanchard; Dominique Heymann
Journal:  Endocrinology       Date:  2008-04-10       Impact factor: 4.736

8.  Macrophage membrane-coated iron oxide nanoparticles for enhanced photothermal tumor therapy.

Authors:  Qian-Fang Meng; Lang Rao; Minghui Zan; Ming Chen; Guang-Tao Yu; Xiaoyun Wei; Zhuhao Wu; Yue Sun; Shi-Shang Guo; Xing-Zhong Zhao; Fu-Bing Wang; Wei Liu
Journal:  Nanotechnology       Date:  2018-04-03       Impact factor: 3.874

Review 9.  Amphibian macrophage development and antiviral defenses.

Authors:  Leon Grayfer; Jacques Robert
Journal:  Dev Comp Immunol       Date:  2015-12-15       Impact factor: 3.636

10.  Hybrid-Actuating Macrophage-Based Microrobots for Active Cancer Therapy.

Authors:  Jiwon Han; Jin Zhen; Van Du Nguyen; Gwangjun Go; Youngjin Choi; Seong Young Ko; Jong-Oh Park; Sukho Park
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more
  9 in total

1.  IL-34 Aggravates Steroid-Induced Osteonecrosis of the Femoral Head via Promoting Osteoclast Differentiation.

Authors:  Feng Wang; Hong Sung Min; Haojie Shan; Fuli Yin; Chaolai Jiang; Yang Zong; Xin Ma; Yiwei Lin; Zubin Zhou; Xiaowei Yu
Journal:  Immune Netw       Date:  2022-03-31       Impact factor: 5.851

Review 2.  Interactions between Macrophages and Mast Cells in the Female Reproductive System.

Authors:  Nadia Lampiasi
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

3.  Two Novel Intronic Mutations in the CSF1R Gene in Two Families With CSF1R-Microglial Encephalopathy.

Authors:  Jiwei Jiang; Wenyi Li; Xiaohong Wang; Zhongli Du; Jinlong Chen; Yaou Liu; Wei Li; Zhonghua Lu; Yanli Wang; Jun Xu
Journal:  Front Cell Dev Biol       Date:  2022-05-24

Review 4.  Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.

Authors:  Zhixia Zhou; Zhan Wang; Jie Gao; Zhijuan Lin; Yin Wang; Peipei Shan; Mengkun Li; Tingting Zhou; Peifeng Li
Journal:  Mol Ther Oncolytics       Date:  2022-03-16       Impact factor: 6.311

5.  Testicular Macrophages Produce Progesterone De Novo Promoted by cAMP and Inhibited by M1 Polarization Inducers.

Authors:  Sawako Yamauchi; Kousuke Yamamoto; Kazushige Ogawa
Journal:  Biomedicines       Date:  2022-02-18

Review 6.  Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges.

Authors:  Virginija Danylaité Karrenbauer; Robert A Harris; Jinming Han; Violeta Chitu; E Richard Stanley; Zbigniew K Wszolek
Journal:  Cell Mol Life Sci       Date:  2022-04-02       Impact factor: 9.207

Review 7.  The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.

Authors:  Yanghong Ni; Xiaoting Zhou; Jia Yang; Houhui Shi; Hongyi Li; Xia Zhao; Xuelei Ma
Journal:  Front Cell Dev Biol       Date:  2021-05-20

8.  Synthesis and Evaluation of a 18F-Labeled Ligand for PET Imaging of Colony-Stimulating Factor 1 Receptor.

Authors:  Hyeokjin Lee; Ji-Hun Park; Hyunjung Kim; Sang-Keun Woo; Joon Young Choi; Kyung-Han Lee; Yearn Seong Choe
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-23

9.  Inhibition of CSF1R, a receptor involved in microglia viability, alters behavioral and molecular changes induced by cocaine.

Authors:  Maria Carolina Machado da Silva; Giovanni Freitas Gomes; Heliana de Barros Fernandes; Aristóbolo Mendes da Silva; Antônio Lúcio Teixeira; Fabrício A Moreira; Aline Silva de Miranda; Antônio Carlos Pinheiro de Oliveira
Journal:  Sci Rep       Date:  2021-08-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.